The lack of correlation between hallucinogenesis and inhibition of axoplasmic transport.
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000494:pharmacology; D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001370:Axonal Transport; D001369:Axons / Q000187:drug effects / Q000378:metabolism*; D001692:Biological Transport; D006213:Hallucinogens / Q000494:pharmacology*; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008635:Mescaline / Q000494:pharmacology; D004130:N,N-Dimethyltryptamine / Q000494:pharmacology; D009900:Optic Nerve / Q000378:metabolism; D011392:Proline / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014316:Tritium
D000470:Alkaloids; D006213:Hallucinogens; D007211:Indoles; D011725:Pyridines; D014316:Tritium; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; D008238:Lysergic Acid Diethylamide; D011392:Proline; D008635:Mescaline; D004130:N,N-Dimethyltryptamine